AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home mLife Article
PDF (1.4 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Rethinking the tumor microbiome: Methodological challenges and a framework for rigorous research

Lingxuan Zhu1,#, Zhixing Deng1,#, Weiming Mou1,2,#, Gengwen Deng1,3, Hongyu Lu1,4, Liling Xu1, Shujia Lin1, Hongsen Huang1,3, Keren Wu1, Qiheng Liang1, Hao Li1, Ziwen Zheng1, Anqi Lin1( ), Peng Luo1,5,6 ( )
Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
The First School of Clinical Medicine, Southern Medical University, Guangzhou, China
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
Department of Microbiology, State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Shantou University Medical College, Shantou, China

#Lingxuan Zhu, Zhixing Deng, and Weiming Mou contributed equally to this study.

Show Author Information

Abstract

The intratumoral microbiome, as an essential component of the tumor microenvironment, has attracted increasing attention in recent years. The tumor microbiota displays an intricate interplay with its biological behaviors. However, emerging controversies, including the retraction of Poore et al.'s article, highlight significant challenges within this field. These issues extend beyond questions of reliability in this particular work to challenge fundamental theoretical assumptions and methodological validity across the entire field of tumor microbiome research, profoundly impacting its future direction. Here, we systematically summarize and discuss the current challenges and limitations in tumor microbiome research. We further propose a series of practical optimization strategies and solutions, from microbial quantification to functional experiments, providing a comprehensive framework covering the entire workflow of tumor microbiome analysis. With ongoing technical progress and standardized protocols, tumor microbiome research is poised to deliver novel insights into tumor biology and contribute to the development of improved therapeutic strategies.

References

【1】
【1】
 
 
mLife
Pages 531-540

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhu L, Deng Z, Mou W, et al. Rethinking the tumor microbiome: Methodological challenges and a framework for rigorous research. mLife, 2026, 5(5): 531-540. https://doi.org/10.1002/mlf2.70107

6

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 19 October 2025
Accepted: 08 July 2026
Published: 26 October 2026
© 2026 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.